NO955046L - Imidazol-lipogenase-inhibitorer - Google Patents
Imidazol-lipogenase-inhibitorerInfo
- Publication number
- NO955046L NO955046L NO955046A NO955046A NO955046L NO 955046 L NO955046 L NO 955046L NO 955046 A NO955046 A NO 955046A NO 955046 A NO955046 A NO 955046A NO 955046 L NO955046 L NO 955046L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- substituted
- halogen
- independently
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14220693 | 1993-06-14 | ||
| PCT/JP1994/000836 WO1994029299A1 (en) | 1993-06-14 | 1994-05-25 | Imidazole lipoxygenase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO955046D0 NO955046D0 (no) | 1995-12-13 |
| NO955046L true NO955046L (no) | 1996-02-13 |
Family
ID=15309865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO955046A NO955046L (no) | 1993-06-14 | 1995-12-13 | Imidazol-lipogenase-inhibitorer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5753682A (cs) |
| EP (1) | EP0703913B1 (cs) |
| KR (1) | KR100190728B1 (cs) |
| CN (2) | CN1050840C (cs) |
| AT (1) | ATE154353T1 (cs) |
| AU (1) | AU685122B2 (cs) |
| BR (1) | BR9406822A (cs) |
| CA (1) | CA2163667C (cs) |
| CZ (1) | CZ282969B6 (cs) |
| DE (1) | DE69403795T2 (cs) |
| DK (1) | DK0703913T3 (cs) |
| ES (1) | ES2103130T3 (cs) |
| FI (1) | FI942792L (cs) |
| GR (1) | GR3024568T3 (cs) |
| HU (1) | HUT70767A (cs) |
| IL (1) | IL109903A (cs) |
| NO (1) | NO955046L (cs) |
| NZ (1) | NZ266541A (cs) |
| PL (2) | PL175987B1 (cs) |
| RU (1) | RU2126004C1 (cs) |
| TW (1) | TW374088B (cs) |
| WO (1) | WO1994029299A1 (cs) |
| ZA (1) | ZA944140B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063928A (en) * | 1994-10-18 | 2000-05-16 | Pfizer Inc | 5-lipoxygenase inhibitors |
| US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
| DE69611101T2 (de) * | 1995-09-18 | 2001-04-05 | Pfizer Inc., New York | Imidazol lipoxygenase inhibitoren |
| TR200003136T2 (tr) * | 1998-04-29 | 2001-03-21 | The Procter & Gamble Company | 1,3-İki ikameli-4-oksosiklik ürelerin yapımı ile ilgili yöntem. |
| SK15842000A3 (sk) * | 1998-04-29 | 2001-06-11 | The Procter & Gamble Company | Spôsob prípravy 1,3-disubstituovaných-4-oxocyklických močovín |
| US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
| US6344563B1 (en) * | 1999-08-31 | 2002-02-05 | Timothy Norris | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| CA2667566C (en) | 2006-11-27 | 2012-01-03 | Pfizer Products Inc. | Pyrazole analogs |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1183847A (en) * | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
| EP0106440B1 (en) * | 1982-08-12 | 1987-11-25 | Smith and Nephew Associated Companies p.l.c. | Wound dressing and its manufacture |
| JPS60142966A (ja) * | 1983-09-05 | 1985-07-29 | Yoshitomi Pharmaceut Ind Ltd | イミダゾ−ル誘導体 |
| US4851526A (en) * | 1987-09-04 | 1989-07-25 | Schering A.G. | 1-(4-Substituted phenyl)-1H-imidazoles compounds |
| US5234950A (en) * | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
| GB8926981D0 (en) * | 1988-12-23 | 1990-01-17 | Ici Plc | Heterocyclic derivatives |
| US5223525A (en) * | 1989-05-05 | 1993-06-29 | Rhone-Poulenc Ag Company | Pesticidal 1-arylimidazoles |
| IE64358B1 (en) * | 1989-07-18 | 1995-07-26 | Ici Plc | Diaryl ether heterocycles |
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| GB9101375D0 (en) * | 1991-01-22 | 1991-03-06 | Erba Carlo Spa | N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole |
| GB9108811D0 (en) * | 1991-04-24 | 1991-06-12 | Erba Carlo Spa | N-imidazolyl derivatives of substituted indole |
-
1994
- 1994-05-25 CZ CZ953276A patent/CZ282969B6/cs not_active IP Right Cessation
- 1994-05-25 ES ES94916398T patent/ES2103130T3/es not_active Expired - Lifetime
- 1994-05-25 PL PL94312006A patent/PL175987B1/pl unknown
- 1994-05-25 BR BR9406822A patent/BR9406822A/pt not_active Application Discontinuation
- 1994-05-25 US US08/553,546 patent/US5753682A/en not_active Expired - Fee Related
- 1994-05-25 AU AU68077/94A patent/AU685122B2/en not_active Ceased
- 1994-05-25 EP EP94916398A patent/EP0703913B1/en not_active Expired - Lifetime
- 1994-05-25 CN CN94192439A patent/CN1050840C/zh not_active Expired - Fee Related
- 1994-05-25 AT AT94916398T patent/ATE154353T1/de not_active IP Right Cessation
- 1994-05-25 RU RU96100073A patent/RU2126004C1/ru active
- 1994-05-25 DE DE69403795T patent/DE69403795T2/de not_active Expired - Fee Related
- 1994-05-25 KR KR1019950705659A patent/KR100190728B1/ko not_active Expired - Fee Related
- 1994-05-25 PL PL94326494A patent/PL176522B1/pl unknown
- 1994-05-25 WO PCT/JP1994/000836 patent/WO1994029299A1/en not_active Ceased
- 1994-05-25 CA CA002163667A patent/CA2163667C/en not_active Expired - Fee Related
- 1994-05-25 NZ NZ266541A patent/NZ266541A/en unknown
- 1994-05-25 DK DK94916398.4T patent/DK0703913T3/da active
- 1994-05-30 TW TW083104929A patent/TW374088B/zh active
- 1994-06-06 IL IL10990394A patent/IL109903A/en not_active IP Right Cessation
- 1994-06-13 FI FI942792A patent/FI942792L/fi unknown
- 1994-06-13 ZA ZA944140A patent/ZA944140B/xx unknown
- 1994-06-13 HU HU9401762A patent/HUT70767A/hu unknown
-
1995
- 1995-12-13 NO NO955046A patent/NO955046L/no unknown
-
1997
- 1997-08-28 GR GR970402207T patent/GR3024568T3/el unknown
-
1999
- 1999-06-10 CN CN99108414A patent/CN1247191A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69929689D1 (de) | Heterozyclische derivate für die behandlung von herzversagen und andere erkrankungen | |
| DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
| NO20092050L (no) | Nye sulfonamidderivater som bradykininantagonister | |
| NO20071140L (no) | Nye piperidinderivater som histamin H3 reseptorligander for behandling av depresjon | |
| NO20054414L (no) | Dihydropteridinoner, metoder for deres fremstilling og bruk av disse som medisiner | |
| NO20051406L (no) | Indolderivater som beta-2 agonister | |
| NO953305L (no) | Antranilsyrederivat | |
| NO20066055L (no) | Pyridinderivater | |
| NO955046L (no) | Imidazol-lipogenase-inhibitorer | |
| NO20044764L (no) | 1-(aminoalkyl)-3-sulfonylindol og -indazolderivater som 5-hydroksytryptamin-6 ligander | |
| AR056582A1 (es) | COMPUESTOS DE PIRAZOLIL UREA CON ACTIVIDAD INHIBITORIA DE CINASA P38 Y FORMULACIoN FARMACÉUTICA QUE LO COMPRENDE | |
| KR920006322A (ko) | 벤젠, 피리딘 및 피리미딘 유도체 | |
| NO20061395L (no) | Nye pyridinderivater | |
| NO982072L (no) | Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase | |
| DK266686A (da) | 1-aryl-5-alkoximinoalkylaminopyrazoler, fremgangsmaader til fremstilling deraf og deres anvendelse som herbicider og vaekstregulatorer | |
| NO20061045L (no) | Imidazolderivater | |
| NO20055749L (no) | Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer | |
| NO20081195L (no) | Imidazopyridinderivater som kannabinoidreceptorligander | |
| DE502004007738D1 (de) | Stilben-derivate und deren verwendung in arzneimitteln | |
| NO992316L (no) | Benzensulfonamidderivater og legemidler inneholdende disse | |
| DE69421183D1 (de) | Heteroaryl-cyloalkenyl-hydroxy-harnstoeffe | |
| NO992870D0 (no) | Difenylalkyl-tetrahydropyridiner, fremgangsmÕter for deres fremstilling og farmas°ytiske blandinger inneholdende dem | |
| NO20065659L (no) | 3-((4-fenyul)-piperazin-1-yl)-alkyl)-3alkyl-1, 3-dihydro-2H-indol-2-on derivater og relaterte forbindelser for behandling av forstyrrelser i sentralnervesystemet | |
| NO20064835L (no) | Fungisidblandinger | |
| NO924947L (no) | Tetrazolderivater og legemidler |